5-fluorouridine has been researched along with Bladder Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Fukushima, S; Kubota, Y; Miura, T; Moriyama, M; Ooshima, H; Shiozaki, H; Shuin, T | 1 |
Au, JL; Gan, Y; Song, D; Wientjes, MG | 1 |
2 other study(ies) available for 5-fluorouridine and Bladder Cancer
Article | Year |
---|---|
Combination chemotherapy for metastatic urinary bladder cancer with 5-FU, vincristine, bleomycin, cyclophosphamide, mitomycin, and methotrexate.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Carcinoma, Transitional Cell; Cyclophosphamide; Female; Humans; Male; Methotrexate; Middle Aged; Mitomycins; Uridine; Urinary Bladder Neoplasms; Vincristine | 1984 |
Bladder tissue pharmacokinetics and antitumor effect of intravesical 5-fluorouridine.
Topics: Administration, Intravesical; Animals; Antibiotics, Antineoplastic; Biological Availability; Dogs; Female; Fluorouracil; Humans; Male; Metabolic Clearance Rate; Uridine; Urinary Bladder; Urinary Bladder Neoplasms | 1997 |